BCSFVSDNA• 3 Months (Normalized)
BCSF vs DNA (Bain Capital Specialty Finance Inc. vs Ginkgo Bioworks Holdings Inc.)
Showing Closing Date Range from Jul 7 to Oct 5, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BCSF Performance $10.9
-14.11%
Bain Capital Specialty Finance Inc.
Normalized Baseline0.00%
DNA Performance $14.98
+60.39%
Ginkgo Bioworks Holdings Inc.
Normalized Baseline0.00%
Alpha Spread Margin DNA LEADS
-74.5 pts
DNA outperforming by 74.50 percentage points
BCSFDNA
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BCSF DNA
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(64 dates)
| Date | BCSF Price | BCSF Gain (%) | DNA Price | DNA Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 05, 2026 | $10.90 | -14.11% | $14.98 | +60.39% | -74.50% |
| Oct 02, 2026 | $11.05 | -12.92% | $12.35 | +32.23% | -45.15% |
| Oct 01, 2026 | $- | $12.50 | +33.83% | - | |
| Sep 30, 2026 | $- | $12.83 | +37.37% | - | |
| Sep 29, 2026 | $- | $11.96 | +28.05% | - | |
| Sep 28, 2026 | $- | $10.46 | +11.99% | - | |
| Sep 25, 2026 | $11.08 | -12.69% | $10.66 | +14.13% | -26.82% |
| Sep 24, 2026 | $11.12 | -12.37% | $10.25 | +9.74% | -22.11% |
| Sep 23, 2026 | $11.07 | -12.77% | $8.58 | -8.14% | -4.63% |
| Sep 22, 2026 | $11.22 | -11.58% | $9.37 | +0.32% | -11.90% |
| Sep 21, 2026 | $11.21 | -11.66% | $7.98 | -14.56% | +2.90% |
| Sep 18, 2026 | $11.09 | -12.61% | $7.88 | -15.63% | +3.02% |
| Sep 17, 2026 | $11.30 | -10.95% | $7.84 | -16.06% | +5.11% |
| Sep 16, 2026 | $11.08 | -12.69% | $7.06 | -24.41% | +11.72% |
| Sep 15, 2026 | $11.07 | -12.77% | $6.99 | -25.16% | +12.39% |
Page 1 of 5